Dashboard
Manage Tickers

ZURAZura Bio Ltd

Nasdaq zurabio.com


$ 3.51 $ 0.20 (6.06 %)    

Wednesday, 11-Sep-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 3.5
$ 3.50 x 200
-- x --
-- - --
$ 2.00 - $ 7.22
227,059
na
42M
$ 0.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-28-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 04-11-2022 12-31-2021 10-K
12 11-19-2021 09-30-2021 10-Q
13 08-27-2021 03-31-2021 10-Q
14 08-27-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-initiates-coverage-on-zura-bio-with-neutral-rating-announces-price-target-of-5
HC Wainwright & Co. Initiates Coverage On ...
09/05/2024 10:59:16

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Zura Bio (NASDAQ:ZURA) with a Neutral rating and annou...

zura-bio-filed-for-mixed-shelf-offering-of-up-to-300m
Zura Bio Filed For Mixed Shelf Offering Of...
09/03/2024 20:52:23

cantor-fitzgerald-reiterates-overweight-on-zura-bio
Cantor Fitzgerald Reiterates Overweight on...
08/15/2024 12:20:34

Cantor Fitzgerald analyst Josh Schimmer reiterates Zura Bio (NASDAQ:ZURA) with a Overweight.

zura-bio-q2-eps-017-up-from-131-yoy
Zura Bio Q2 EPS $(0.17) Up From $(1.31) YoY
08/13/2024 13:22:43

Core News & Articles
Watching Monte Rosa Therapeutics, Zura Bio...
07/01/2024 15:29:49

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-jump-at-least-300-says-piper-sandler/

cantor-fitzgerald-reiterates-overweight-on-zura-bio
Cantor Fitzgerald Reiterates Overweight on...
06/17/2024 13:29:16

Cantor Fitzgerald analyst Josh Schimmer reiterates Zura Bio (NASDAQ:ZURA) with a Overweight.

zura-bio-shares-supportive-data-from-phase-1-study-evaluating-lead-candidate-tibulizumab-zb-106-for-treatment-of-sjogrens-syndrome
Zura Bio Shares Supportive Data From Phase...
06/14/2024 10:09:25

These data, along with preclinical data supporting further development of tibulizumab in rheumatoid arthritis (RA), were presen...

cantor-fitzgerald-initiates-coverage-on-zura-bio-with-overweight-rating
Cantor Fitzgerald Initiates Coverage On Zu...
06/12/2024 11:43:33

Cantor Fitzgerald analyst Josh Schimmer initiates coverage on Zura Bio (NASDAQ:ZURA) with a Overweight rating.

zura-bio-highlights-dual-pathway-antibody-tibulizumab-at-upcoming-eular-2024-conference
Zura Bio Highlights Dual-Pathway Antibody ...
06/03/2024 10:06:48

Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio"), a clinical-stage immunology company developing novel dual-pathway antibodi...

oppenheimer-maintains-outperform-on-zura-bio-raises-price-target-to-21
Oppenheimer Maintains Outperform on Zura B...
05/10/2024 16:48:54

Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and raises the price target from $16 to $21.

zura-bio-q1-2024-gaap-eps-002-beats-023-estimate
Zura Bio Q1 2024 GAAP EPS $(0.02) Beats $(...
05/09/2024 10:16:30

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.23) by 9...

piper-sandler-initiates-coverage-on-zura-bio-with-overweight-rating-announces-price-target-of-26
Piper Sandler Initiates Coverage On Zura B...
05/03/2024 09:36:15

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Zura Bio (NASDAQ:ZURA) with a Overweight rating and announces Pri...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
04/26/2024 16:31:22

zura-bio-announces-oversubscribed-1125m-private-placement-for-201m-class-a-shares-at-a-price-of--3108-per-share-financing-includes-new-and-existing-leading-life-sciences-institutional-investors-strengthened-balance-sheet-expected-to-fund-operations-through-2027
Zura Bio Announces Oversubscribed $112.5M ...
04/18/2024 13:23:45

- Financing includes new and existing leading life sciences institutional investors- Strengthened balance sheet expected to fun...

zura-bio-announces-that-robert-lisicki-has-assumed-the-role-of-chief-executive-officer-and-a-director
Zura Bio Announces That Robert Lisicki Has...
04/08/2024 10:11:02

Succeeds Founding CEO, Dr. Someit Sidhu, who will continue as a Board Director Recognized as inspirational industry leader w...

oppenheimer-reiterates-outperform-on-zura-bio-lowers-price-target-to-16
Oppenheimer Reiterates Outperform on Zura ...
04/01/2024 13:33:49

Oppenheimer analyst Jeff Jones reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.

zura-bio-q4-eps-030-misses-023-estimate
Zura Bio Q4 EPS $(0.30) Misses $(0.23) Est...
03/28/2024 12:22:44

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.23) by...

zura-bio-has-appointed-robert-lisicki-as-ceo-effective-april-8-2024-succeeding-someit-sidhu-who-remains-actively-involved-in-the-company-as-a-non-independent-director-of-the-board
Zura Bio Has Appointed Robert Lisicki As C...
03/28/2024 10:26:37

zura-bio-fy23-eps-209-beats-299-estimate-cash-position-of-998m-expected-to-provide-cash-runway-into-into-2026
Zura Bio FY23 EPS $(2.09) Beats $(2.99) Es...
03/28/2024 10:19:56

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/22/2024 17:31:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION